Clinical Trial Update: Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating mitoxantrone with or without docetaxel in women with metastatic breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Mitoxantrone (mitoxantrone)
• Taxotere (docetaxel)

Snippet

Sponsor: Arbeitsgemeinschaft fur Internistische Onkologie | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED